News | March 14, 2024
Cureskin secures US$ 20 million in Series B funding
Cureskin aims to disrupt the large and growing skin and hair care industry in India
Cureskin aims to disrupt the large and growing skin and hair care industry in India
Chlorpromazine Hydrochloride Injection is used to treat certain mental/mood disorders
The drug will target specific genetic mutations prevalent in certain types of cancers
This partnership marks a significant step for the Company towards establishing renewable energy power generation using hybrid open excess through solar and wind sources
From only 80 Jan Aushadhi Kendras in 2014, there are around 11,000 units operating across the country today
Venus Remedies' manufacturing unit, located in Baddi, Himachal Pradesh, has been recommended for supplying cephalosporin dry powder to UNICEF
With just few days of treatment, the patient started responding well and finally complete clinical resolution of infection was attained
CRESEMBA receives seven years and six months of US market exclusivity for these pediatric indications
It is the first autotaxin inhibitor to be investigated in cancer patients
Zydus Lifesciences receives EIR report from USFDA for API Ahmedabad facility
Subscribe To Our Newsletter & Stay Updated
